Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Breast Neoplasms

abstract

  • Eisai.

publication date

  • March 12, 2011

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(11)60070-6

PubMed ID

  • 21376385

Additional Document Info

start page

  • 914

end page

  • 23

volume

  • 377

number

  • 9769